Medical Device Startups and IT: What I Learned Before I Founded SOL-I.S.

Before I founded SOL-I.S. in 2009, I spent a decade in the medical device industry, advancing from R&D electronics into IT management and consulting. That background shapes how we serve life sciences companies today, and it is why so many of our longest client relationships started in that world. One of them ran for roughly 14 years.

Early-stage medical device and life sciences companies face a technology problem that most startups do not. They have to move fast and stay disciplined at the same time, because the systems they build early will eventually live inside a regulated, audited environment. The shortcuts that are forgivable in other industries are not forgivable here.

The tension every device startup feels

A young device company is usually racing toward a milestone: a design freeze, a submission, a funding round, a clinical study. Technology often gets treated as something to deal with later, set up quickly and cheaply so the science can move.

The problem is that “later” arrives faster than anyone expects, and by then the casual decisions have hardened into the foundation. Quality systems, document control, data integrity, and access control are all far easier to build correctly from the start than to retrofit under the pressure of an audit or an acquisition.

What gets overlooked early

In my experience, these are the areas device and life sciences startups most often underinvest in:

• Data integrity and access control. In a regulated environment, who can change what, and whether you can prove it, matters enormously. Loose permissions early become a serious liability later.
• Document and version control. Quality systems live or die on controlled documents. Ad hoc file sharing does not survive scrutiny.
• IP protection. Your designs and data are the company’s entire value. Protecting them is not optional, especially with investors and partners involved.
• Backups and continuity. Losing study data or design history is not an inconvenience in this industry. It can be existential.
• Scalability. Virtual and lean today, but built to expand. The infrastructure should not have to be torn out the first time you grow.

Build for the audit you cannot see yet

The companies that handle this well think one step ahead. They do not over-engineer, but they make early decisions with the regulated future in mind. That foresight is exactly what an experienced IT partner brings, and it is hard to get from a generalist who has never worked inside the industry.

This is the core of why we treat medical device and life sciences as a flagship industry at SOL-I.S. It is not a vertical we picked off a list. It is where I came from, and it is work we genuinely understand.

If you are building in this space

Whether you are a virtual startup heading toward your first study or an established firm scaling up, the goal is the same: technology that supports the science, protects the data, and holds up under scrutiny.

If that is where you are, let’s talk. You will be working with people who have actually been inside your world.